Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi

Overview of attention for article published in Frontiers in immunology, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

Protective efficacy of the oral vaccine Tc24:Co1 produced in Schizochytrium sp. against Trypanosoma cruzi infection in a mouse model

Article in Microbial Pathogenesis (December 2023)

cGAS-STING signaling pathway in intestinal homeostasis and diseases

Article in Frontiers in Immunology (September 2023)

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells

Article in Current Research in Immunology (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.